A phase III study of high-dose intensification without hematopoietic progenitor cells support for patients with high-risk primary breast carcinoma. [electronic resource]
Producer: 20000707Description: 292-6 p. digitalISSN:- 0277-3732
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Breast Neoplasms -- drug therapy
- Breast Neoplasms, Male -- drug therapy
- Carcinoma -- drug therapy
- Chemotherapy, Adjuvant
- Cisplatin -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Lymphatic Metastasis
- Male
- Middle Aged
- Risk Factors
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.